Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Valvular Heart Disease

Free Subscription 01.09.2025 2 Am Heart J 3 Am J Cardiol 6 Ann Thorac Surg 1 Circulation 2 Eur Heart J 3 Eur J Cardiothorac Surg 2 Heart 3 Int J Cardiol 2 J Am Coll Cardiol 1 J Am Soc Echocardiogr 1 Pediatr Cardiol 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. HARVEY JE 3RD, Ryan M, Gunnarsson C, Chikermane S, et al
   Incremental cost of complications after TAVR and SAVR in contemporary clinical practice.
   Am Heart J. 2025;290:278-287.
   PubMed         Abstract available
   
   
2. WEI C, Sharma P, Paranjpe I, Heidenreich PA, et al
   Balancing cost and care: Analyzing commercial pricing for TAVR and SAVR.
   Am Heart J. 2025;290:1-5.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

3. VERDINO RJ
   Improving Functional Mitral Regurgitation by Catheter Ablation of Atrial Fibrillation - Yet Another Benefit of this Widely Performed Procedure.
   Am J Cardiol. 2025 Aug 27:S0002-9149(25)00502.
   PubMed        
   
   
4. FABRIS T, Strosio M, Putorti F, Mesiani C, et al
   Guiding Early Management in Severe Mitral Stenosis with Extensive Mitral Annular Calcification: A Transseptal ViMAC Case.
   Am J Cardiol. 2025 Aug 26:S0002-9149(25)00495.
   PubMed         Abstract available
   
   
5. ALBOSTA M, Eleid M, Deshmukh A
   Predictors of the need for pacemaker after transcatheter tricuspid valve replacement: an early experience.
   Am J Cardiol. 2025 Aug 26:S0002-9149(25)00503.
   PubMed        
   
   

   
   Ann Thorac Surg

6. LU T, Zhu C, Cui H, Meng Y, et al
   Predictors of N-Terminal Pro-Brain Natriuretic Peptide Nonresponse and Its Impact on Outcomes in Patients After Septal Myectomy.
   Ann Thorac Surg. 2025;120:511-520.
   PubMed         Abstract available
   
   
7. HAMMOUD MS, Chen L, Toth AJ, Rajeswaran J, et al
   Long-Term Clinical Outcomes and Health-Related Quality of Life After the Ross Procedure.
   Ann Thorac Surg. 2025;120:502-510.
   PubMed         Abstract available
   
   
8. DANIAL P, Frering A, Bouhdadi H, Juvin C, et al
   Lower Ministernotomy: An Approach for Treating All Valvulopathies?
   Ann Thorac Surg. 2025;120:487-493.
   PubMed         Abstract available
   
   
9. AGUAYO E, Kwon OJ, Won M, Mallick S, et al
   Impact of Transcatheter Aortic Valve Replacement Volume on Outcomes in Patients with End Stage Renal Disease.
   Ann Thorac Surg. 2025 Aug 27:S0003-4975(25)00796.
   PubMed         Abstract available
   
   
10. MOROI MK, Vinogradsky AV, Feng I, Cordoves EM, et al
    Melody versus Mechanical Mitral Valve Replacement in Young Children: A Single-Center Propensity Matched Analysis.
    Ann Thorac Surg. 2025 Aug 25:S0003-4975(25)00794.
    PubMed         Abstract available
    
    
11. GAN LX, Chen FY, Jian XH
    Anterior Leaflet Involvement in Mitral Valve Infective Endocarditis: When is Valve Repair Feasible?
    Ann Thorac Surg. 2025 Aug 25:S0003-4975(25)00780.
    PubMed        
    
    

    
    Circulation

12. FEISTRITZER HJ, Ender J, Lauten P, Rudolph TK, et al
    Peri-interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Non-inferiority Trial.
    Circulation. 2025 Aug 29. doi: 10.1161/CIRCULATIONAHA.125.076557.
    PubMed         Abstract available
    
    

    
    Eur Heart J

13. PRAZ F, Borger MA, Lanz J, Marin-Cuartas M, et al
    2025 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2025 Aug 29:ehaf194. doi: 10.1093.
    PubMed        
    
    
14. LURZ P, Hahn RT, Kodali S, Makkar R, et al
    Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
    Eur Heart J. 2025 Aug 29:ehaf676. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

15. SALEM R, Rashid H, Karimian-Tabrizi A, Hlavicka J, et al
    Twenty years' experience with minimally invasive aortic valve repair.
    Eur J Cardiothorac Surg. 2025 Aug 29:ezaf294. doi: 10.1093.
    PubMed         Abstract available
    
    
16. PRAZ F, Borger MA, Lanz J, Marin-Cuartas M, et al
    2025 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur J Cardiothorac Surg. 2025;67:ezaf276.
    PubMed        
    
    
17. KOFLER M, Berretta P, Bonaros N, Cresce GD, et al
    Endo-aortic balloon occlusion Vs. transthoracic clamping in minimally invasive mitral valve surgery.
    Eur J Cardiothorac Surg. 2025 Aug 26:ezaf258. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

18. JEONG JH, Kim H, Hwang SH, Seo CO, et al
    Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy.
    Heart. 2025 Apr 7:heartjnl-2024-325218. doi: 10.1136/heartjnl-2024-325218.
    PubMed         Abstract available
    
    
19. KUBO T, Sugiura K, Tokita Y, Takano H, et al
    Contemporary clinical characteristics and management patterns in hypertrophic cardiomyopathy: insights from baseline enrolment data in a nationwide prospective Japanese registry.
    Heart. 2025;111:885-892.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

20. DUAN YN
    Letter to the editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025 Aug 26:133829. doi: 10.1016/j.ijcard.2025.133829.
    PubMed        
    
    
21. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to Letter to the Editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Reinterpreting patient characteristics and institutional effects.
    Int J Cardiol. 2025 Aug 26:133830. doi: 10.1016/j.ijcard.2025.133830.
    PubMed        
    
    
22. MARGONATO D, Morosato M, Ingallina G, Wang C, et al
    Natural history outcome of moderate tricuspid regurgitation with preserved left-ventricular ejection fraction.
    Int J Cardiol. 2025;442:133826.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

23. DESAI MY, Braunwald E
    The Pathophysiologic Basis and Management of Calcific Aortic Valve Stenosis: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2025;86:659-672.
    PubMed         Abstract available
    
    
24. KAUL S
    Reappraisal of Evidentiary Support for Transcatheter Aortic Valve Implantation for Low-Risk Aortic Stenosis: Insights From Midterm Results of the PARTNER 3 and Evolut LR Trials.
    J Am Coll Cardiol. 2025 Jul 25:S0735-1097(25)06845.
    PubMed        
    
    

    
    J Am Soc Echocardiogr

25. SILBIGER JJ, Marchenko O, Safi L, Panday P, et al
    Echocardiographic and Pathophysiologic Insights into Mitral Regurgitation, Mitral Annular Disjunction, and Ventricular Arrhythmias in Patients with Mitral Valve Prolapse.
    J Am Soc Echocardiogr. 2025 Aug 25:S0894-7317(25)00473.
    PubMed         Abstract available
    
    

    
    Pediatr Cardiol

26. SHAHID S, Aziz PF, Assaad IE, Burke BJ, et al
    Association between Mitral Valve Pathology and Ventricular Ectopy in the Pediatric Marfan Population.
    Pediatr Cardiol. 2025 Aug 29. doi: 10.1007/s00246-025-03963.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

27. PERLA S, Stiegler AL, Yi JS, Enyenihi L, et al
    SHP2 genetic variants in NSML-associated RASopathies disrupt the PZR-IRX transcription factor signaling axis.
    Proc Natl Acad Sci U S A. 2025;122:e2503631122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.